L&K Biomed Future Growth
Future criteria checks 6/6
L&K Biomed is forecast to grow earnings and revenue by 104.6% and 52.2% per annum respectively. EPS is expected to grow by 105.4% per annum. Return on equity is forecast to be 57.9% in 3 years.
Key information
104.6%
Earnings growth rate
105.4%
EPS growth rate
Medical Equipment earnings growth | 40.9% |
Revenue growth rate | 52.2% |
Future return on equity | 57.9% |
Analyst coverage | Low |
Last updated | 02 Nov 2023 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 94,500 | 19,400 | 11,600 | 17,400 | 1 |
12/31/2024 | 61,200 | 9,200 | 6,900 | 11,700 | 1 |
12/31/2023 | 29,905 | -1,867 | -3,469 | -1,370 | N/A |
9/30/2023 | 28,227 | -1,835 | -701 | 360 | N/A |
6/30/2023 | 27,208 | -3,047 | -4,958 | -4,105 | N/A |
3/31/2023 | 23,962 | -8,674 | -5,649 | -5,507 | N/A |
12/31/2022 | 19,767 | -13,625 | -6,791 | -6,881 | N/A |
9/30/2022 | 17,757 | -12,891 | -9,750 | -11,166 | N/A |
6/30/2022 | 14,816 | -15,989 | -10,058 | -11,647 | N/A |
3/31/2022 | 15,183 | -15,229 | -9,915 | -11,253 | N/A |
12/31/2021 | 15,373 | -9,669 | -10,035 | -10,600 | N/A |
9/30/2021 | 16,385 | -16,005 | -9,329 | -8,524 | N/A |
6/30/2021 | 19,043 | -12,500 | -6,837 | -3,530 | N/A |
3/31/2021 | 17,924 | -7,924 | -6,244 | -3,347 | N/A |
12/31/2020 | 19,356 | -10,715 | -2,958 | -777 | N/A |
9/30/2020 | 21,730 | -2,825 | 790 | 3,394 | N/A |
6/30/2020 | 21,554 | -4,653 | 91 | 448 | N/A |
3/31/2020 | 24,330 | -9,806 | 1,376 | 1,896 | N/A |
12/31/2019 | 26,575 | -10,766 | -932 | 1 | N/A |
9/30/2019 | 27,082 | -12,727 | -4,500 | -3,196 | N/A |
6/30/2019 | 32,048 | -10,051 | -8,765 | -6,686 | N/A |
3/31/2019 | 31,076 | -3,969 | -10,866 | -8,698 | N/A |
12/31/2018 | 31,323 | -3,772 | -12,412 | -10,383 | N/A |
9/30/2018 | 31,078 | -8,964 | -10,904 | -9,586 | N/A |
6/30/2018 | 28,293 | -12,427 | -6,919 | -5,845 | N/A |
3/31/2018 | 30,438 | -14,049 | -6,346 | -5,262 | N/A |
12/31/2017 | 31,514 | -14,829 | -6,890 | -4,918 | N/A |
9/30/2017 | 29,981 | -5,437 | N/A | -7,233 | N/A |
6/30/2017 | 29,881 | -3,565 | N/A | -7,272 | N/A |
3/31/2017 | 33,910 | -1,224 | N/A | -8,648 | N/A |
12/31/2016 | 34,449 | 1,446 | N/A | -8,371 | N/A |
12/31/2015 | 32,046 | 6,300 | N/A | -2,324 | N/A |
12/31/2014 | 20,224 | -4,720 | N/A | -312 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A156100 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.5%).
Earnings vs Market: A156100 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: A156100 is expected to become profitable in the next 3 years.
Revenue vs Market: A156100's revenue (52.2% per year) is forecast to grow faster than the KR market (9.1% per year).
High Growth Revenue: A156100's revenue (52.2% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A156100's Return on Equity is forecast to be very high in 3 years time (57.9%).